Healthcare

Buyers group makes $4.59 bln bid for China Biologic: Reuters

A consortium of buyers has made a $4.59 billion takeover bid for China Biologic, reported Reuters. The buyer group includes CITIC Capital China Partners. China Biologic is a developer of plasma-based therapies.

Bain Capital-backed Arosa LivHOME to buy LifeLinks

Arosa+LivHOME, which is backed by Bain Capital, has agreed to acquire LifeLinks, a provider of aging life care services in Raleigh, North Carolina and Nashville. No financial terms were disclosed.

WCAS inks $250 mln deal for American Health Imaging

Beekman invests in Twin Boro

The Beekman Group has made an investment in Clark, New Jersey-based Twin Boro Management LLC, a management services organization supporting a network of physical and occupational therapy clinics. No financial terms were disclosed.

Hong Leong Group and TPG to buy Columbia Asia Hospitals

Hong Leong Group and TPG have agreed to acquire Columbia Asia Hospitals in South East Asia. The purchase price is $1.2 billion. The deal is expected to close at the end of 2019.

Warburg snaps up Qualifacts in $300 mln-plus deal, following larger bet for WebPT

Envista debuts IPO

Brea, California-based Envista, a dental products company being spun out of Danaher, raised over $588 million for its IPO after pricing its over 26.7 million shares at $22 per share. The stock began trading September 18, 2019 on the New York Stock Exchange under the ticker symbol "NVST." J.P. Morgan, Goldman Sachs and Morgan Stanley are the lead underwriters.

Colorcon unveils $50 mln corporate venture fund

Harleysville, Pennsylvania-based Colorcon, a provider of specialty products for the pharmaceutical industry, has launched a $50 million corporate venture fund. Colorcon Ventures will invest in "promising" companies in the pharmaceutical industry. Touchdown Ventures will help manage the Colorcon Ventures fund.

Dental Intelligence scores $34 mln Series A

Utah-based Dental Intelligence, an analytics and workflow automation platform for dental practices, has raised $34 million in Series A funding. The investor was K1 Investment Management.

New Harbor sells KureSmart to Clearway Pain Solutions

Clearway Pain Solutions, a portfolio company of NexPhase Capital, has acquired KureSmart Pain Management from New Harbor Capital. No financial terms were disclosed. Headquartered in Annapolis, Maryland, KureSmart Pain Management provides comprehensive support services to pain management physicians.